Market revenue in 2023 | USD 8,636.1 million |
Market revenue in 2030 | USD 14,033.3 million |
Growth rate | 7.2% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.81% in 2023. Horizon Databook has segmented the Europe formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
The European Medicine Agency (EMA) covers 25% market of worldwide pharmaceutical sales, and this is one of the leading drivers for outsourcing trends related to formulation developments in the life sciences sector, as a higher number of drugs in requirement would mean greater demand for formulation development services by pharma or biotech companies in the region.
In addition, the research support and demand for personalized medicines are increasing among the European population, owing to their growing awareness. For instance, European Commission, in collaboration with over 30 International & European members who represent policy-making organizations and research funders, established an international consortium for Personalized Medicine.
This consortium has developed research-supporting activities in areas related to personalized human medicines. Such funding & support from government organizations are boosting the demand for formulation development outsourcing services.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe formulation development outsourcing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account